DISCOUNT ZERTIFIKAT - ABBVIE Share Price

Certificat

DE000PN58FE5

Delayed Deutsche Boerse AG 16:20:30 26/06/2024 BST
109.2 EUR +0.38% Intraday chart for DISCOUNT ZERTIFIKAT - ABBVIE
Current month+1.82%
1 month+2.07%
Date Price Change
26/06/24 109.2 +0.38%
25/06/24 108.8 +0.22%
24/06/24 108.6 -0.33%
21/06/24 108.9 +0.17%
20/06/24 108.7 +0.35%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 04:20 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN58FE
ISINDE000PN58FE5
Date issued 21/07/2023
Maturity 20/12/2024 (177 Days)
Parity 1 : 1
Emission price 91.86
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 109.2
Lowest since issue 94.62
Spread 0.05
Spread %0.05%

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
170.8 USD
Average target price
183.2 USD
Spread / Average Target
+7.31%
Consensus